首页> 外文期刊>International Journal of Physiology, Pathophysiology and Pharmacology >Effect of angiotensin II type 1 receptor blocker on renal function, arterial blood pressure and parathyroid hormone related protein over expression in cadmium induced nephrotoxicity in adult male rats
【24h】

Effect of angiotensin II type 1 receptor blocker on renal function, arterial blood pressure and parathyroid hormone related protein over expression in cadmium induced nephrotoxicity in adult male rats

机译:血管紧张素Ⅱ1型受体阻滞剂对成年雄性大鼠镉致肾毒性的肾功能,动脉血压和甲状旁腺激素相关蛋白过度表达的影响

获取原文
           

摘要

Objective: To study the possible effect of angiotensin II type 1 Receptor blocker (AT1 blocker) on renal function, arterial blood pressure and parathyroid hormone related protein over expression in cadmium induced nephrotoxicity in adult male rats. Forty five rats were divided randomly into a control (group I), group II, received cadmium chloride at a dose of 5 mg/kg/day, orally, for nine weeks, group III received telmisartan (TEL) treatment (1 mg/kg/day, orally) one week before cadmium administration and continued for ten weeks. Results: Telmisartan significantly reduced blood urea nitrogen (BUN) and serum creatinine levels which were increased significantly by cadmium. Telmisartan significantly suppressed lipid peroxidation, compensated deficits in the antioxidant defenses (super oxide dismutase (SOD) level and catalase activity), decreased the elevations of nitric oxide (NO) and cadmium ion concentrations in renal tissue observed in Cd-treated rats. Group III had a significant decrease of urinary levels of total protein, N-acetyl-β-d-glucosaminidase (NAG), alkaline phosphatase (ALP) and γ-glutamyl-transpeptidase (GGT) and urinary 8-isoprostanes than those of group II. Telmisartan decreased the systolic blood pressure significantly than those of group II. Histopathological examination revealed that cadmium-induced renal tissue damage was ameliorated by telmisartan treatment. Immunohistochemical analysis revealed that telmisartan significantly decreased the cadmium-induced overexpression of parathyroid hormone receptor 1 (PTHR1) in renal tissue. RT-PCR analysis showed that Cd increased renal expression of PTHrP; however telmisartan could decrease the expression of PTHrP in group III. Conclusion: Blocking AT1 receptors significantly decreases PTHrP over expression and ameliorates renal dysfunction in Cd induced nephrotoxicity. These data suggest that Ang II might contribute to pathophysiology and deleterious effects in cadmium nephrotoxicity.
机译:目的:研究血管紧张素Ⅱ1型受体阻滞剂(AT1阻滞剂)对成年雄性大鼠镉致肾毒性的肾功能,动脉血压和甲状旁腺激素相关蛋白表达的影响。将四十五只大鼠随机分为对照组(第一组),第二组,以5 mg / kg /天的剂量接受氯化镉,口服九周,第三组接受替米沙坦(TEL)治疗(1 mg / kg)每天一次(口服)/天(每天口服),持续10周。结果:替米沙坦显着降低了血尿素氮(BUN)和血清肌酐水平,而镉显着提高了血尿素氮水平。替米沙坦显着抑制脂质过氧化,补偿抗氧化剂防御系统的缺陷(超氧化物歧化酶(SOD)水平和过氧化氢酶活性),降低镉治疗大鼠肾脏组织中一氧化氮(NO)和镉离子浓度的升高。第三组尿中总蛋白,N-乙酰基-d-氨基葡萄糖苷酶(NAG),碱性磷酸酶(ALP)和&#x003b3-谷氨酰转肽酶(GGT)和尿液8的尿水平显着降低异前列腺素比第二组。替米沙坦的收缩压明显低于第二组。组织病理学检查显示,替米沙坦治疗可减轻镉引起的肾组织损伤。免疫组织化学分析显示,替米沙坦显着降低了镉诱导的肾组织中甲状旁腺激素受体1(PTHR1)的过度表达。逆转录-聚合酶链反应(RT-PCR)分析表明,镉可增加肾组织PTHrP的表达。然而替米沙坦可能降低III组PTHrP的表达。结论:阻断AT1受体可显着降低PTHrP过表达,并改善Cd致肾毒性的肾功能不全。这些数据表明Ang II可能有助于镉肾毒性的病理生理学和有害作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号